CN116568285A - 水性组合物 - Google Patents

水性组合物 Download PDF

Info

Publication number
CN116568285A
CN116568285A CN202180059005.XA CN202180059005A CN116568285A CN 116568285 A CN116568285 A CN 116568285A CN 202180059005 A CN202180059005 A CN 202180059005A CN 116568285 A CN116568285 A CN 116568285A
Authority
CN
China
Prior art keywords
mass
aqueous composition
salts
acid
test example
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180059005.XA
Other languages
English (en)
Chinese (zh)
Inventor
久保大空
林纱衣子
喜多亚希子
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rohto Pharmaceutical Co Ltd
Original Assignee
Rohto Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rohto Pharmaceutical Co Ltd filed Critical Rohto Pharmaceutical Co Ltd
Publication of CN116568285A publication Critical patent/CN116568285A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN202180059005.XA 2020-07-30 2021-07-30 水性组合物 Pending CN116568285A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020-129728 2020-07-30
JP2020129728 2020-07-30
PCT/JP2021/028439 WO2022025279A1 (ja) 2020-07-30 2021-07-30 水性組成物

Publications (1)

Publication Number Publication Date
CN116568285A true CN116568285A (zh) 2023-08-08

Family

ID=80036428

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180059005.XA Pending CN116568285A (zh) 2020-07-30 2021-07-30 水性组合物

Country Status (9)

Country Link
US (1) US20230285562A1 (https=)
EP (1) EP4176882A4 (https=)
JP (1) JPWO2022025279A1 (https=)
KR (1) KR20230047400A (https=)
CN (1) CN116568285A (https=)
AU (1) AU2021318236A1 (https=)
CA (1) CA3190310A1 (https=)
TW (1) TWI908843B (https=)
WO (1) WO2022025279A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024194105A1 (en) * 2023-03-17 2024-09-26 Leo Pharma A/S A method for the treatment of chronic hand eczema in patients with moderate to severe chronic hand eczema
WO2025032221A1 (en) * 2023-08-09 2025-02-13 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Jak-inhibitor for the treatment of ten, sjs and sjs/ten overlap
EP4506005A1 (en) * 2023-08-09 2025-02-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Jak-inhibitor for the treatment of ten, sjs and sjs/ten overlap

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105636590A (zh) * 2013-10-21 2016-06-01 日本烟草产业株式会社 眼病的治疗剂或预防剂
CN114173788A (zh) * 2019-08-07 2022-03-11 乐敦制药株式会社 泪液分泌促进用眼科组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2018229A1 (en) * 1970-04-16 1971-10-28 Ferrous sulphate stabilized with citric acid
CL2009001884A1 (es) * 2008-10-02 2010-05-14 Incyte Holdings Corp Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco.
HK1251223A1 (en) 2015-07-07 2019-01-25 Japan Tobacco, Inc. Method for producing 7h-pyrrolo[2, 3-d]pyrimidine derivative and intermediate thereof
KR102702286B1 (ko) 2016-12-21 2024-09-04 니뽄 다바코 산교 가부시키가이샤 7H-피롤로[2,3-d]피리미딘 유도체의 제조 방법 및 그의 공결정
EP4674401A3 (en) * 2019-12-27 2026-02-25 Rohto Pharmaceutical Co., Ltd Container accommodating an aqueous ophthalmic composition comprising delgocitinib
US20230285564A1 (en) * 2020-07-30 2023-09-14 Rohto Pharmaceutical Co., Ltd. Aqueous Composition

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105636590A (zh) * 2013-10-21 2016-06-01 日本烟草产业株式会社 眼病的治疗剂或预防剂
CN114173788A (zh) * 2019-08-07 2022-03-11 乐敦制药株式会社 泪液分泌促进用眼科组合物

Also Published As

Publication number Publication date
EP4176882A1 (en) 2023-05-10
TWI908843B (zh) 2025-12-21
TW202220658A (zh) 2022-06-01
EP4176882A4 (en) 2024-01-10
KR20230047400A (ko) 2023-04-07
AU2021318236A1 (en) 2023-03-09
JPWO2022025279A1 (https=) 2022-02-03
US20230285562A1 (en) 2023-09-14
WO2022025279A1 (ja) 2022-02-03
CA3190310A1 (en) 2022-02-03

Similar Documents

Publication Publication Date Title
JP7224390B2 (ja) アトロピン含有水性組成物
CN116568285A (zh) 水性组合物
AU623191B2 (en) Pharmaceutical compositions containing n-(3,4- dimethoxycinnamoyl)anthranilic acid
CN116568286A (zh) 水性组合物
JP2021046394A (ja) ブリモニジンとチモロールとを含む、緑内障罹患患者における眼圧を下降させるための組成物
JP2025019313A (ja) 涙液分泌促進用眼科組成物
ES2414557A1 (es) Composición acuosa de paracetamol para inyección
JP5834427B2 (ja) ソフトコンタクトレンズへの吸着抑制方法
JP5753958B2 (ja) 澄明な水性液剤
HK40091389A (zh) 水性组合物
HK40091721A (zh) 水性组合物
WO2013147000A1 (ja) ２－アミノ－３－（４－ブロモベンゾイル）フェニル酢酸含有水性組成物
HK40003059B (zh) 含有阿托品的水性组合物
HK40066213A (zh) 泪液分泌促进用眼科组合物
CN112007031A (zh) 眼用制剂

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40091389

Country of ref document: HK